GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Shanghai Pharmaceuticals Holding Co Ltd (SHSE:601607) » Definitions » Total Liabilities

Shanghai Pharmaceuticals Holding Co (SHSE:601607) Total Liabilities : ¥135,331 Mil (As of Mar. 2024)


View and export this data going back to 1994. Start your Free Trial

What is Shanghai Pharmaceuticals Holding Co Total Liabilities?

Shanghai Pharmaceuticals Holding Co's Total Liabilities for the quarter that ended in Mar. 2024 was ¥135,331 Mil.

Shanghai Pharmaceuticals Holding Co's quarterly Total Liabilities declined from Sep. 2023 (¥133,002.75 Mil) to Dec. 2023 (¥131,646.44 Mil) but then increased from Dec. 2023 (¥131,646.44 Mil) to Mar. 2024 (¥135,331.31 Mil).

Shanghai Pharmaceuticals Holding Co's annual Total Liabilities increased from Dec. 2021 (¥104,369.30 Mil) to Dec. 2022 (¥120,132.45 Mil) and increased from Dec. 2022 (¥120,132.45 Mil) to Dec. 2023 (¥131,646.44 Mil).

Shanghai Pharmaceuticals Holding Co Total Liabilities Historical Data

The historical data trend for Shanghai Pharmaceuticals Holding Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Pharmaceuticals Holding Co Total Liabilities Chart

Shanghai Pharmaceuticals Holding Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 87,640.47 94,444.93 104,369.30 120,132.45 131,646.44

Shanghai Pharmaceuticals Holding Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 126,154.93 134,375.23 133,002.75 131,646.44 135,331.31

Shanghai Pharmaceuticals Holding Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Shanghai Pharmaceuticals Holding Co's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=122371.879+(7336.231+1938.331
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=131,646

Total Liabilities=Total Assets (A: Dec. 2023 )-Total Equity (A: Dec. 2023 )
=211972.534-80326.093
=131,646

Shanghai Pharmaceuticals Holding Co's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=125273.429+(8135.457+1922.423
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=135,331

Total Liabilities=Total Assets (Q: Mar. 2024 )-Total Equity (Q: Mar. 2024 )
=217416.957-82085.647
=135,331

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Pharmaceuticals Holding Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of Shanghai Pharmaceuticals Holding Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai Pharmaceuticals Holding Co (SHSE:601607) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Shanghai Pharmaceuticals Holding Co Ltd (SHSE:601607) » Definitions » Total Liabilities
Comparable Companies
SHSE:600511 SZSE:000028 SHSE:600056 SHSE:600739 SZSE:000950 SHSE:603368 SZSE:002589 SZSE:002551 MCK COR CAH HSIC HKSE:01099 MIL:AMP NZSE:EBO XSWX:GALE TSE:7459 TSE:2784 PDCO TSE:9987
Traded in Other Exchanges
SHPMY:USA SHPMF:USA 02607:Hong Kong S1R:Germany
Address
No. 200 Taicang Road, Shanghai Pharmaceutical Building, Shanghai, CHN, 200020
Website
https://www.sphchina.com
Shanghai Pharmaceuticals Holding is a vertically integrated Chinese healthcare company that operates drug manufacturing, distribution, and retail pharmacy businesses in mainland China. It is the second-largest distributor by revenue and has a strong distribution presence in Eastern China.
Executives
Ren Jian senior management
Liu Yan Jun senior management
Hu Feng Xiang Director
Zuo Min Director
Guo Jun Yu senior management
Han Min senior management
Lou Ding Bo Director
Chen Xin Supervisors
Shu Chang senior management
Li Yong Zhong senior management
Jiang Yuan Ying senior management
Xu Guo Xiong Director
Shen Bo senior management
Ge Jian Qiu senior management

Shanghai Pharmaceuticals Holding Co (SHSE:601607) Headlines

No Headlines